Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquinol-cytochrome c reductase hinge protein pseudogene 4 (UQCRHP4) is a human pseudogene related to complex III of the mitochondrial respiratory chain. Unlike functional protein-coding genes, UQCRHP4 does not produce a protein and has no enzymatic, transport, receptor, or signaling activity. Pseudogenes arise from gene duplication or retrotransposition events but accumulate mutations that disable their coding potential, rendering them non-functional. UQCRHP4 is therefore not considered a molecular target in drug discovery, disease association, or therapeutic applications. There is no evidence that UQCRHP4 encodes a receptor, enzyme, transporter, or other therapeutic target, and no literature supports its involvement in biological processes or disease roles. This entry is best classified as a non-target pseudogene and is not relevant for most applications in drug development or molecular biology.
None (as there is no protein product, there are no mechanisms of action relevant to drug targeting)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase hinge protein pseudogene 4 (UQCRHP4).